These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15580194

  • 1. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
    Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB.
    J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
    [Abstract] [Full Text] [Related]

  • 2. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE, Carrel AL, Whitman BY, Allen DB.
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 4. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.
    Festen DA, Wevers M, Lindgren AC, Böhm B, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):919-25. PubMed ID: 18031326
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.
    Eiholzer U, L'allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C.
    J Pediatr; 2004 Jun; 144(6):753-8. PubMed ID: 15192622
    [Abstract] [Full Text] [Related]

  • 6. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
    Bosio L, Beccaria L, Benzi F, Sanzari A, Chiumello G.
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
    [Abstract] [Full Text] [Related]

  • 7. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE, Siemensma EP, Koopman C, Hokken-Koelega AC.
    Horm Res Paediatr; 2015 Apr; 83(5):321-31. PubMed ID: 25764996
    [Abstract] [Full Text] [Related]

  • 8. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
    Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB.
    Am J Med Genet A; 2007 Mar 01; 143A(5):443-8. PubMed ID: 17103437
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC, Lindberg A.
    Horm Res; 2008 Mar 01; 70(3):182-7. PubMed ID: 18663319
    [Abstract] [Full Text] [Related]

  • 10. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
    Carrel AL, Allen DB.
    J Pediatr Endocrinol Metab; 2001 Mar 01; 14 Suppl 6():1445-51. PubMed ID: 11837498
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
    Whitman B, Carrel A, Bekx T, Weber C, Allen D, Myers S.
    J Pediatr Endocrinol Metab; 2004 Apr 01; 17(4):591-600. PubMed ID: 15198290
    [Abstract] [Full Text] [Related]

  • 12. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C, Thorén M, Böhm B.
    J Intellect Disabil Res; 2005 Apr 01; 49(Pt 4):245-52. PubMed ID: 15816811
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.
    Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C.
    Growth Horm IGF Res; 2011 Aug 01; 21(4):185-90. PubMed ID: 21664161
    [Abstract] [Full Text] [Related]

  • 14. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M, Deal C, Van Vliet G.
    J Pediatr; 2009 Feb 01; 154(2):230-3. PubMed ID: 18814886
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
    Carrel AL, Myers SE, Whitman BY, Allen DB.
    J Pediatr; 1999 Feb 01; 134(2):215-21. PubMed ID: 9931532
    [Abstract] [Full Text] [Related]

  • 16. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
    Höybye C.
    Acta Paediatr; 2007 Mar 01; 96(3):410-3. PubMed ID: 17407467
    [Abstract] [Full Text] [Related]

  • 17. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U, Schlumpf M, Nordmann Y, l'Allemand D.
    J Pediatr Endocrinol Metab; 2001 Mar 01; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [Abstract] [Full Text] [Related]

  • 18. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL, Myers SE, Whitman BY, Allen DB.
    J Pediatr Endocrinol Metab; 2001 Mar 01; 14(8):1097-105. PubMed ID: 11592566
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR, Lee PD, Whitman BY, Zipf WB, Frey M, Myers S, Cahan M, Pinyerd B, Southren AL.
    J Clin Endocrinol Metab; 2008 Apr 01; 93(4):1238-45. PubMed ID: 18211968
    [Abstract] [Full Text] [Related]

  • 20. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A, Choi JH, Sohn YB, Eom Y, Lee J, Yoo HW, Jin DK.
    Orphanet J Rare Dis; 2019 Sep 11; 14(1):216. PubMed ID: 31511031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.